NCT01324635 2025-05-02Panobinostat and Stereotactic Radiation Therapy in Treating Patients With Brain TumorsThomas Jefferson UniversityPhase 1 Terminated17 enrolled
NCT00859222 2017-03-14LBH589 and Bevacizumab in Patients With Recurrent High Grade GliomaDana-Farber Cancer InstitutePhase 1/2 Completed51 enrolled 18 charts
NCT00848523 2010-07-16Study of LBH589 (Panobinostat) to Treat Malignant Brain TumorsNeurological Surgery, P.C.Phase 2 Terminated6 enrolled